NL-OMON54835已完成4 期
Stop TPO-receptor agonist in ITP Patients - STIP study
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Persistent or chronic ITP, 18 years old, in need of second line therapy after
- •initial treatment with corticosteroids, informed consent
排除标准
- •Previous splenectomy, Bone marrow disease, Other bleeding disorder, Liver
- •disease (Child Pugh above 7), Pregnancy, Secondary ITP, prior TPO-RA use
- •(longer than 3 months of therapy)
研究者
相似试验
招募中
不适用
STIP studyNL-OMON22827Haga Teaching Hospital, The Hague50
已完成
4 期
Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITPPersistent or Chronic ITPNCT03119974Assistance Publique - Hôpitaux de Paris48
尚未招募
4 期
Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP PatientsPrimary Immune ThrombocytopeniaNCT05311930Wuhan Union Hospital, China69
招募中
3 期
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis - a double-blind, placebo-controlled trialK74K65R18K72K72.79R17A49K76.7Fibrosis and cirrhosis of liverAscitesHepatic failure, not elsewhere classifiedHyperbilirubinaemia, with or without jaundice, not elsewhere classifiedBacterial infection of unspecified sitePeritonitisHepatorenal syndromeDRKS00021290niversitätsklinikum Hamburg-Eppendorf476
招募中
4 期
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)2023-509863-26-00University Medical Center Hamburg-Eppendorf476